tiprankstipranks
Trending News
More News >
Viracta Therapeutics (VIRX)
OTHER OTC:VIRX
US Market

Viracta Therapeutics (VIRX) Technical Analysis

Compare
933 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Technical Analysis Consensus
Neutral
0Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Viracta Therapeutics’s (VIRX) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Viracta Therapeutics is a Sell.
Viracta Therapeutics’s (VIRX) 20-Day exponential moving average is 0.02, while Viracta Therapeutics’s (VIRX) share price is <$0.1, making it a Sell.
Viracta Therapeutics’s (VIRX) 50-Day exponential moving average is 0.05, while Viracta Therapeutics’s (VIRX) share price is <$0.1, making it a Sell.

Viracta Therapeutics (VIRX) Pivot Points

Apr 08, 2025, 07:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.02
0.02
0.03
0.03
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Viracta Therapeutics (VIRX) Moving Averages

Apr 08, 2025, 07:35 PM
Period
Simple
Exponential
MA5
0.02Sell
0.02Sell
MA10
0.02Sell
0.02Sell
MA20
0.02Sell
0.02Sell
MA50
0.04Sell
0.05Sell
MA100
0.11Sell
0.11Sell
MA200
0.22Sell
0.26Sell
Viracta Therapeutics’s (VIRX) 10-Day exponential moving average is 0.02, while Viracta Therapeutics’s (VIRX) share price is <$0.1, making it a Sell.
Viracta Therapeutics’s (VIRX) 100-Day exponential moving average is 0.11, while Viracta Therapeutics’s (VIRX) share price is <$0.1, making it a Sell.
Viracta Therapeutics’s (VIRX) stock price is <$0.1 and Viracta Therapeutics’s (VIRX) 50-day simple moving average is 0.04, creating a Sell signal.
Viracta Therapeutics’s (VIRX) stock price is <$0.1 and Viracta Therapeutics’s (VIRX) 100-day simple moving average is 0.11, creating a Sell signal.
Viracta Therapeutics’s (VIRX) stock price is <$0.1 and Viracta Therapeutics’s (VIRX) 200-day simple moving average is 0.22, creating a Sell signal.

Viracta Therapeutics (VIRX) Technical Indicators

Apr 08, 2025, 07:35 PM
Name
Value
Implied Action
RSI (14)
42.49
Neutral
STOCH (9,6)
-20.37
Buy
STOCHRSI (14)
-3.70
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
26.31
Neutral
Williams %R
-111.11
Buy
CCI (14)
-58.03
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
27.13
Sell
ROC
0.00
Sell
Viracta Therapeutics’s (VIRX) Relative Strength Index (RSI) is 42.49, creating a Neutral signal.
Viracta Therapeutics’s (VIRX) Trend Strength Indicator (ADX) is 26.31, creating a Neutral signal.
Viracta Therapeutics’s (VIRX) Commodity Channel Index (CCI) is -58.03, creating a Neutral signal.

FAQ

Is VIRX a Buy, Hold, or Sell?
Based on VIRX’s technical indicators, VIRX is a Strong Sell.
    What is VIRX’s RSI (14)?
    VIRX’s RSI (14) is 42.49, which suggests VIRX is a Neutral.
      What is VIRX’s MACD?
      VIRX’s MACD is >-0.01, which suggests VIRX is a Sell.
        What is VIRX’s 5-day moving average?
        VIRX’s 5-day moving average is 0.02, which suggests VIRX is a Sell.
          What is VIRX’s 20-day moving average?
          VIRX 20-day moving average is 0.02, which suggests VIRX is a Sell.
            What is VIRX’s 50-day moving average?
            VIRX’s 50-day moving average is 0.04, which suggests VIRX is a Sell.
              What is VIRX’s 200-day moving average?
              VIRX’s 200-day moving average is 0.22, which suggests VIRX is a Sell.
                What is VIRX’s Williams % R (14)?
                VIRX’s Williams % R (14) is -111.11, which suggests VIRX is a Buy.
                  What is VIRX’s CCI (14)?
                  VIRX’s CCI (14) is -58.03, which suggests VIRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis